Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (TCTR20250929005) titled 'Respiratory Syncytial Virus Hospitalizations Among Adults in Thailand: A Nationwide Retrospective Observational Study (RSV-HAT)' on Sept. 29.
Study Type: Observational
Primary Sponsor: GlaxoSmithKline (Thailand) Limited
Condition:
RSV infection in Adult 18+
Respiratory Syncytial Virus, Thailand, Hospitalization, Health Care Utilization
Respiratory Syncytial Virus, Thailand, Hospitalization, Health Care Utilization
Intervention:
Adult RSV-related hospitalization 18 year and above
Other
Recruitment Status: Not Recruiting
Date of First Enrollment: 01/06/2016
Target Sample Size: 626
Countries of Recruitme...